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Abstract
The need for clearly-defined health research
policies and priorities has been emphasized in
the international scenario. In Brazil, this process
began in 2003, when a group appointed by the
National Health Council proposed 20 sub-
agendas to account for the various health re-
search specificities. The second step was to iden-
tify research priorities for each sub-agenda
during national seminars involving 510 re-
searchers and policymakers. The 2nd National
Conference on Science, Technology, and Inno-
vation in Health was held in July 2004. During
the preparatory phase, 307 cities and 24 States
organized local conferences, involving 15,000
participants. Some 360 health sector delegates
were appointed during the local conferences,
in addition to those from the education and
science and technology sectors. During the Con-
ference, the national policy was approved and
3 other sub-agendas were introduced and ap-
proved. The national policy and the priority
agenda are currently guiding investments by
the Ministry of Health for research and devel-
opment, and to a certain extent those from the
Ministry of Science and Technology as well.
From 2003 to 2005, 24 calls for proposals were
launched; as a result, 3,962 research projects
were submitted and 1,300 financed.
Research; Consumer Participation; Health Policy
Introduction
United Nations Secretary-General Kofi Annan
recently addressed the issue of Science for All
Nations, highlighting that “no nation that
wants to shape informed policies and take effec-
tive action … can afford to be without its own
independent capacity in S&T”, and “every na-
tion should develop a S&T strategy that reflects
local priorities” 1 (p. 925).
The need to establish health research poli-
cies and priorities at a global level has been
emphasized, taking into account that the social
and environmental contexts that determine
disease are no longer national in scope, but in-
creasingly global: health-determining phe-
nomena transcend national borders and politi-
cal jurisdictions 2.
The Commission on Health Research for
Development (CHRD), created in 1987, worked
to determine the status and the factors con-
straining health and health research in non-in-
dustrialized countries. Many of the Commis-
sion’s findings elaborate on the inequity theme,
describing large disparities in how resources
are distributed, research priorities are defined,
and research capacities are strengthened (or
neglected). Four mains actions were recom-
mended: encourage countries to undertake es-
sential national health research, address com-
mon health problems through international
partnerships, mobilize larger and more sus-
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tained financial support, and establish an in-
ternational mechanism to monitor progress
and promote financial and technical support
for research on health problems in developing
countries. The Commission’s 1990 report al-
ready identified the challenge to establish co-
herence in research responses to high-priority
problems at the national and international lev-
els: “…each developing country will need to set
national priorities for research, for using both
domestic and external resources….” 3 (p. 88-9).
A direct follow-up of the Commission’s rec-
ommendations was the interim Task Force on
Health Research for Development (TFHRD),
established in 1991. With respect to setting pri-
orities, the Task Force analyzed the problem as
follows: “The mechanisms for identifying re-
search priorities often fail to focus attention on
the key issues affecting the health of the majori-
ty of the population, especially the needs of the
most vulnerable and the disadvantaged” 4 (p.
24). Priorities are usually narrowly constructed
along disciplinary lines and oriented chiefly
towards medical technology. Each interested
group – scientists, health policymakers, health-
care providers, and the population/patients –
had a different perspective on the issues need-
ing most urgent attention. The policy setting
process usually failed to effectively accommo-
date these differing views to achieve a consen-
sus on goals and strategies for health research 4.
Some tools and methodologies were devel-
oped for health research policy setting, like bur-
den-of-disease analysis, the five-step process,
combined-approach methodologies, etc. The
importance of fairness and procedural justice
in setting priorities is clear, and careful atten-
tion to consensus-building increases the likeli-
hood of compliance and adds legitimacy to re-
sults. Despite some progress, the methodologi-
cal debate on policy setting, particularly at the
national level, is more open than ever 5,6.
Facilitated by the Council on Health Re-
search for Development (COHRED), which re-
placed the TFHRD in 1993, an increasing num-
ber of developing countries started experiment-
ing with and implementing health research
policy setting 6. Few experiences were reported
in the international literature, and when so, as
very short reports 7.
However, in our opinion, equal considera-
tion should be given not only to setting policies
and establishing priorities, but also on how to
implement them into actual programs and
projects. The present article describes how this
was accomplished in a middle-income country
and in a relatively short period of time. While
working in the Department of Science and Tech-
nology (Departamento de Ciência e Tecnologia –
DECIT) in the Brazilian Ministry of Health, the
authors designed and conducted the establish-
ment of a National Policy for Science, Technol-
ogy, and Innovation in Health and the Priority
Agenda for Health Research. The article de-
scribes the policy’s implementation and two-
year follow-up. It also reports in some detail on
this innovative and participatory experience,
which, although responding to the specificities
of the Unified National Health System (Sistema
Único de Saúde – SUS), could be reproduced in
other settings, given adequate political will and
financial support.
Context of the Brazilian health system
The health system was profoundly modified af-
ter the 1988 Brazilian Constitution, due to an
extensive health reform based on proposals set
forth during the 8th National Health Confer-
ence (1986). The basic principles guiding the
SUS are: decentralization, comprehensive care
(promotion, protection, early diagnosis, preven-
tion, and rehabilitation), universal coverage,
equity, and community participation.
Presently, three main health delivery sys-
tems coexist in the country: the SUS, which
provides free care to all residents in the coun-
try (with a population of some 175 million), the
Supplementary Health System (SHS) run by pri-
vate healthcare insurance companies or health
cooperatives (covering 35 million paying mem-
bers), and the Private Health System (PHS), to-
tally private, used only by the highest-income
population. Some criticize that although “pri-
vate”, both the SHS and PHS receive govern-
ment subsidies, because all incurrent costs can
be claimed as personal income tax write-offs,
thus diminishing state revenues 8.
Unified National Health System (SUS) num-
bers are impressive: in 2003, it accounted for
268 million medical consultations, 83 million
immunizations, and 12 million hospitalizations 9.
In many circumstances the higher-income pop-
ulation also relies on the SUS, especially in cer-
tain renowned public hospitals, emergency care,
and some exceptionally efficient SUS programs
like organ transplantation, AIDS care, and im-
munizations.
Funding for the SUS is guaranteed by Con-
stitutional Amendment 29 10, approved in 2000,
according to which Federal funds should in-
crease at a rate of 5% a year and States and mu-
nicipalities are obliged to spend 12% and 15% of
their respective revenues on health. The amend-
ment was instrumental for maintaining certain
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stability in Federal health expenditures, around
1.85% of the GDP from 2000 to 2003. More im-
portantly, it improved health investments by
States and municipalities: in the period 2000-
2003, during which time their average expendi-
tures increased from 0.57% to 0.79% and from
0.67% to 0.91%, respectively, of the GDP 11.
In 2001, distribution of Federal health funds
was: (1) 12.2% to municipalities for primary
healthcare (PAB – allocation proportional to
population size); (2) 40.6% to States and mu-
nicipalities to fund secondary and tertiary
healthcare (outpatient and hospital care); (3)
13.8% to municipalities for special public health
programs (PAB variable); (4) 33.4% to pay pri-
vate hospitals that deliver secondary and ter-
tiary healthcare to SUS patients 9. Unified Na-
tional Health System (SUS) governance is shared
at the three levels of government as illustrated
schematically in Figure 1.
A landmark of SUS is community participa-
tion, guaranteed by a network of more than
5,000 Municipal Health Councils, 27 State Health
Councils, and the National Health Council, in-
volving some 100,000 individuals in this volun-
tary work. The four social sectors are represent-
ed in these councils: clientele or community
representatives (50%), health providers plus
health managers (25%), and healthcare work-
ers (25%). Most of the decisions on healthcare
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at the three governmental levels, such as bud-
get, construction of health facilities, implemen-
tation of health programs, etc., must be ap-
proved by health councils 10. The participatory
process reaches its peak during the National
Health Conferences: the latest, held in Decem-
ber 2003, involved approximately 300,000 peo-
ple at three levels: municipal, State, and na-
tional. National Health Conferences are an in-
tegral part of the Brazilian health system be-
cause they play a central role in shaping the
country’s health policies. In addition to the 12
general conferences held so far, thematic con-
ferences are also organized to deal with more
specific issues, such as science and technology
in health.
The Brazilian scientific community played
a central role in designing the health reform
and shaping the SUS. Implementation of the
SUS depended greatly on popular demands
and was a conquest of our politically-engaged
public health scientists. We should mention
here the late Sergio Arouca (1942-2003) as one
of our finest examples of an extremely produc-
tive scientist and equally active politician. He
chaired the seminal 8th National Health Con-
ference in 1986 and was elected to the Brazil-
ian National Congress shortly thereafter, where
he spearheaded the approval of the health re-
form in the 1988 Constitution.
Figure 1
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An overview of health research in Brazil
In 2004, 6,471 research groups were involved in
health research in Brazil, with 25,562 researchers
(15,978 of whom with PhDs), corresponding to
about 30% of total research efforts in Brazil
(Figure 2). These data were retrieved from the
national scientific information systems devel-
oped by the National Research Council (Con-
selho Nacional de Desenvolvimento Científico
e Tecnológico; CNPq) Lattes Platform, Directo-
ry of Research Groups in Brazil, 2002: http://
lattes.cnpq.br/diretorio, accessed on 07/Oct/
2005), more specifically the “research group di-
rectory”. These systems are now the basis of
ScienTI, a recently established international
scientific network which covers all scientific
fields. Since 2002, under international bilateral
agreements, CNPq has transferred information
technology to the National Science and Tech-
nology Councils of nine countries (Argentina,
Chile, Colombia, Equator, Panama, Paraguay,
Peru, Portugal, and Venezuela). More recently,
Cuba, Mexico, and Uruguay have shown inter-
est in joining Red ScienTI, the international
scientific network, and CvLAC, the system for
human resources in science and technology 12.
Guimarães 13 analyzed the performance of
medical and biomedical research in Brazil based
on data from the Institute for Scientific Infor-
mation (ISI). The growth of indexed Brazilian
publications in all scientific fields was impres-
sive, increasing 165-fold from 1973 to 2001
(while during the same period global science
output increased 2.18-fold), for a growth rate
76 times greater than the international sce-
nario of scientific publications. In 1997-2001
Brazil occupied 23rd place among the 30 coun-
tries with the largest science output in the
medical field and 21st in the biomedical field.
Brazil was the only Latin American country
represented in the former ranking and was fol-
lowed by Mexico (29th) in the latter. Research
interests and expertise cover a broad spectrum
of disciplines and applications, from basic re-
search to internal medicine and numerous
others. However, in some crucial areas for the
SUS, health research is incipient, notably in
health technology assessment and health eco-
nomics.
A preliminary estimate of funds invested in
health research from 2000 to 2002 showed an
annual mean of US$573 million, as seen in
Table 1. The public sector accounted for 72.8%,
the private for-profit sector 23.7%, and exter-
nal funds 3.5%14. Until 2003 there was no na-
tional policy for science and technology in
health, nor a priority agenda, so the choice of
health research topics was left entirely to sci-
entists. The Ministry of Health rarely influenced
major decisions on health research investments.
Proposing a policy for science, 
technology, and innovation in health
The new Brazilian Administration which took
office in January 2003 emphasized the central
role of the national health authority (Ministry
of Health) in structuring national health re-
search efforts. It created the opportunity to
draft a National Policy for Science, Technology,
and Innovation in Health, which was approved
during the 2nd National Conference on Science,
Technology, and Innovation in Health held in
July 2004, as described below in more detail.
That policy was based on two main princi-
ples, the first of which was the pursuit of health
equity. Inequity is the Achilles’ heel of Brazilian
society. Regional indicators, as well as indica-
tors referring to different social groups, show
considerable social discrimination concerning
health when patterns of morbidity, mortality,
access to services, and quality in service proce-
dures are examined. Increasing equity in the
health system is the first principle of the Na-
tional Policy for Science, Technology, and In-
novation in Health. Other authors have sug-
gested that research should also increase equi-
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within nations, because the knowledge gener-
ated can be utilized to improve the performance
of the health system and, ultimately, health and
health equity 2,15. The foundations of an effective
global health research endeavor should strength-
en national health research capacities, togeth-
er with the commitment to reduce inequalities
both within and between countries 16.
Commenting on the issue of priority set-
ting, the World Health Organization (WHO) di-
rector for research policy and cooperation
added another key principle: “health research
should be based on sound ethical principles and
avoid exploitation of vulnerable populations” 17
(p. 1399). There is no doubt that increasing re-
strictions and rising costs observed in the de-
veloped countries regarding experiments in
anima nobile within their borders have stimu-
lated the “exportation” of research projects,
particularly clinical protocols and vaccine tri-
als. Some of these protocols are expected to be
applied in the populations of developing coun-
tries under circumstances that would be unac-
ceptable in the country of origin. Strict adher-
ence to ethical standards in health research is
the second principle of the Brazilian policy.
A draft proposal for a National Policy for
Science, Technology, and Innovation in Health
was prepared by the National Health Council
sub-committee on Science and Technology, in-
cluding 56 items. The purpose was to have a
backbone document to discuss during the 2nd
National Conference on Science, Technology,
and Innovation in Health. It was part of the Con-
ference Manual, a document organized and
published by DECIT/Ministry of Health 18.
Establishing a Priority Agenda 
for Health Research
The need to focus health research on high-pri-
ority problems at the national level has been
pointed out in the international scenario over
the past decade, as described previously. How-
ever, much has been said about the “need to”,
but not so much about “how to”. The political
process to guarantee an adequate and broad
consensus is not an easy task, especially if one
wants not only to involve small scientific com-
mittees, but also to extend the horizons to the
community at large.
The establishment of a comprehensive agen-
da for health research priorities in Brazil began
in June 2003, when the Ministry of Health ap-
pointed a Technical Advisory Committee, com-
prised of 20 distinguished scientists and health
policymakers. This group, in consonance with
the National Health Council sub-committee on
Science and Technology, proposed 21 sub-agen-
das to address the specificities and breadth of
the health research area, listed in Table 2 (sub-
agendas highlighted in Table 2 were incorpo-
rated afterwards, during the 2nd National Con-
ference on Science, Technology, and Innova-
tion in Health).
The next step was to identify research pri-
orities for each sub-agenda, which began dur-
ing a national seminar on November 6-7, 2003,
convening 408 professionals, especially health
researchers (68%), health policymakers, and
healthcare providers (32%). Separate seminars
were held previously to set research priorities
on two subjects: “Dengue Fever” and “Violence,
Accidents, and Trauma”, with participation by
102 professionals, because these calls for pro-
posals were planned for 2003. Therefore, the fi-
nal number of specialists and policymakers in-
volved in the entire process was 510. The range
of experts involved biomedical, clinical, and
public health researchers as well as health poli-
cymakers and healthcare providers at the mu-
nicipal, State, and Federal levels.
The choice of participants guaranteed that
all relevant actors and stakeholders were ade-
quately represented. Regarding invited re-
searchers, criteria were experience and publi-
cations in the field, as well as a leading position
in the national scientific scenario. The choice
was based on data retrieved from the national
scientific information systems of CNPq, as al-
ready mentioned. Healthcare providers and
Table 1
Expenditures in health research in Brazil, 2000/2002, according to main 
sources of funding (US$).
Sources 2000/2002 Annual mean
Federal government 680,449,513 226,816,504
Ministry of Health 97,907,787 32,635,929
Ministry of Science and Technology 153,165,909 51,055,303
Ministry of Education 429,375,817 143,125,272
State governments 571,479,120 190,493,040
State Secretaries of Education 412,450,191 137,483,397
and Science
State Agencies for the Development 159,028,929 53,009,643
of Science
Public sector 1,251,928,633 417,309,544
Private sector 406,928,244 135,642,748
International agencies and organizations 60,468,724 20,156,241
Total 1,719,325,601 573,108,534
Source: Ministério da Saúde 14.
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policymakers were chosen at all three levels
(Federal, State and municipal), considering
their contribution and experience in the spe-
cific area of a particular sub-agenda.
For both types of participants, the final choic-
es were guided by a strong concern to guaran-
tee a fair distribution as far as gender and State
of origin, so that the country’s five regions and
most of the States were represented. The largest
number of participants was from Brasília, the
national capital, where the Ministry of Health
has its headquarters, followed by Rio de Janei-
ro, home to the Oswaldo Cruz Foundation (Fun-
dação Oswaldo Cruz – FIOCRUZ), the largest
Brazilian Ministry of Health research institute.
Meetings were organized in groups of 15-25
individuals per sub-agenda with coordinators
and rapporteurs appointed by the DECIT. Lo-
gistic support was provided to make the process
of drafting proposals as interactive as possible.
At the end of the two-day meeting, proposals
were immediately made public to all partici-
pants. For each of the 20 sub-agendas, some 15
to 40 priority topics were proposed.
After minor editorial changes, the agenda
was submitted to a formal public consultation
on the Ministry of Health website for 45 days,
aiming to expand the consultation and reach
health professionals and the community at
large 19. During this period 1,900 individuals
registered online to access the document. A to-
tal of 360 comments and contributions were
received, analyzed, published, and made avail-
able to be discussed during the Conference. All
versions of these documents were saved for
further consultation.
Second National Conference on Science,
Technology, and Innovation in Health
Historical background: the 1st National Confer-
ence on Science and Technology in Health was
held in 1994, and although it represented a
breakthrough, its organization did not allow
ample participation. However, some of the pro-
posals set forth during the Conference, like the
creation of a Science and Technology Secretari-
at, were implemented by the new Brazilian Ad-
ministration in early 2003.
Political aspects: the 2nd National Confer-
ence on Science, Technology, and Innovation
in Health, held on July 25-28, 2004, was an ini-
tiative by three Ministries: Health, Education, and
Science and Technology. During the preparato-
ry phase, lasting some three and a half months,
307 cities and 24 States (out of 27) organized
their local conferences, involving some 15,000
participants. Three hundred and sixty health
sector delegates were appointed by the local
conferences for the national phase. In addition,
120 delegates were named by the education
sector and 120 by the science and technology
sector. There were 644 participants, most of
whom were health researchers, coordinators of
graduate courses, university hospital managers,
representatives of the main scientific societies,
etc. Figure 3 shows the distribution of partici-
pants. The Minister of Health and numerous
other high-level government officials were pre-
sent to open the Conference plenary session.
Logistics: as usual in Brazilian health con-
ferences, State Health Councils organized local
conferences and meetings, usually extending
Table 2
National agenda for health research priorities. Brazil, 2004.
Research sub-agendas approved by the 2nd National Conference on Science, Technology, and Innovation in Health
01. Indigenous peoples' health 13. Health industrial complex (equipment, vaccines, drugs, diagnostic devices)
02. Mental health 14. Health technology assessment / Health economics
03. Violence, accidents, and trauma 15. Epidemiology
04. Health of African descendents* 16. Demography in health
05. Chronic diseases 17. Oral health*
06. Health of the elderly 18. Health promotion (risk factors)
07. Child and adolescent health 19. Infectious and parasitic diseases
08. Women's health 20. Communication & information in health
09. Health of people with disabilities* 21. Work in health and health education
10. Food and nutrition 22. Health systems and policies
11. Bioethics and ethics in research 23. Health, environment, labor, and bio-safety
12. Clinical research 24. Pharmaceutical assistance
* Sub-agendas highlighted were incorporated during the 2nd National Conference on Science, Technology, and Innovation in Health.
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through the weekend in order to maximize the
opportunity for community participation. In
all cases, the proportionality of 50% clientele
(community representatives of SUS users), 25%
health managers/healthcare providers, and
25% health workers, was strictly adhered to.
Delegates elected to represent each State in the
National Conference respected this proportion-
ality, which is a standard procedure in Brazil-
ian health conferences. The States provided
transportation (ground or air, as needed) to al-
low participation by their delegations. The Min-
istry of Health provided meeting rooms, ac-
commodations for community representatives,
and meals and local transportation for all par-
ticipants. This is normal procedure in Brazilian
health conferences, and the purpose of the
government’s contribution is to allow partici-
Figure 3
Distribution of participants in the 2nd National Conference on Science, Technology, and Innovation in Health, 
according to categories represented. Brazil 2004.
Universities: 55%
Participants in the 2nd National Conference on Science, Technology, and Innovation in Health 
n = 644 (100%)
Education sector
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pation by community representatives, who
would otherwise be unable to come to Brasília.
Community leaders do not interpret this sup-
port as a potential conflict of interest; they are
absolutely free to exercise their citizens’ rights,
and they openly and heavily criticize the health
policies with which they disagree.
Methodological aspects: the two main themes
of the conference were: (a) the National Policy
for Science, Technology, and Innovation in Health
and (b) the Priority Agenda for Health Research.
The local, regional, and State conferences dis-
cussed the Conference Manual in depth 18. This
publication was organized and published by
DECIT/Ministry of Health on behalf of the Na-
tional Health Council sub-committee on Science
and Technology. It included 56 items describing
the proposal for a National Policy for Science,
Technology, and Innovation in Health, and also
the Priority Agenda for Health Research, drafted
as described previously and comprising 20 sub-
agendas. The process of local/municipal/State
conferences resulted in 24 documents emerging
from each of the States. During the week before
the conference, a group of 31 high-level rappor-
teurs (health professionals, including scien-
tists) was convened to consolidate the final doc-
ument, to be discussed and approved during the
National Conference. This process was facilitat-
ed by software developed by the SUS Depart-
ment of Data and Information Technology (De-
partamento de Informação e Informática do
SUS – DATASUS). The tool allowed editing, addi-
tions, and suppressions to the text, keeping track
of the original text and (very importantly) the
names and States of the delegates proposing the
changes. Color codes were generated automati-
cally for amendments, suppressions, and substi-
tutions as rapporteurs entered the modifications.
As the Conference proceeded, the consolidated
document was displayed on giant screens in the
meeting rooms, so delegates could follow the
proposed changes as they were included. All ver-
sions of the above documents were saved for fur-
ther consultation. Our effort was to overcome
the problem observed in most countries: not ful-
ly documenting the crucial intervening steps
leading to the selection of research priority areas
and topics, thus causing problems of reliability
and credibility 7.
Summary of conference debates: during the
Conference, both the policy document and
agenda were discussed and voted point by
point, preceded by a broad debate. After three
days of intense discussions, explanations, and
deliberations, the policy document was ap-
proved 20. The original policy document was
expanded from 56 to 79 items after incorporat-
ing the proposals approved during the Confer-
ence. The only really contentious point in the
policy document was the proposal to create a
health research support agency. Most scientists
and many policymakers agreed to the propos-
al, while community representatives strongly
opposed it. This was the only point which put
“science” on one side and the “community” on
the other. The concern that the National Health
Council could “lose control” of research funds
was expressed by the opponents; the proposal
was finally voted and rejected. As a result of
this intense participatory process, many re-
search topics were added to the agenda and
three other sub-agendas emerged, with their
corresponding detailed research topics: (a)
Oral Health; (b) Health of African Descendents;
and (c) Health of People with Disabilities, as
shown in Table 3. Not all topics proposed by
patients’ groups were approved, especially
those regarding rare diseases. The Conference
was a challenge for both scientists and com-
munity leaders. Never before had these social
actors made such an effort to speak a common
language, to interact in such depth, and to
openly discuss their sometimes conflicting
points of view.
Implementing the health research 
policy and agenda
The health research policy and agenda are
currently orienting the allocation of Ministry
of Health funds for scientific research and de-
velopment. As stated previously, implement-
ing these into programs and projects has been
the main goal since the beginning. In the peri-
od 2003-2005, the DECIT/Ministry of Health
launched several calls for proposals, as shown
in Table 3.
In 2003, before the policy and agenda were
approved, there were some investments to sup-
port research projects on pressing issues. The
DECIT/Ministry of Health financed projects for
the National Research Taskforce on Dengue
Fever and nine projects for the Brazilian Tuber-
culosis Network, as well as 148 small opera-
tional research projects for the SUS (Table 3).
Research investment in the Dengue Fever Task-
force was shared with the Ministry of Science
and Technology.
Many of the subsequent calls for proposals
(2004-2005) were run jointly by DECIT/Ministry
of Health and the Ministry of Science and Tech-
nology; one (01. Indigenous Peoples’ Health)
was funded by DECIT/Ministry of Health and
the National Health Foundation (Fundação Na-
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Table 3
Calls for Proposals launched by the Science and Technology Department (DECIT), 
Ministry of Health. Brazil, 2003-2005*.
Year Research sub-agenda/Research call for proposals Projects 
Received Approved
2003 19. Tuberculosis Research Network 9 9
19. National Research Taskforce in Dengue** 116 39
22. Operational research for SUS (State-level grant applications)*** 383 148
11. Support to local research ethics committees 103 64
Total for 2003 611 260
2004 03. Violence, accidents, and trauma** 238 61
10. Nutrition and Food Security** 462 85
08/07. Maternal and neonatal mortality 131 41
17. Oral health 220 28
19. Hantavirus and other RNA encapsulated viruses** 40 29
22. Health systems and policies: quality and humanization 162 45
12. Multi-center phase III trial on the use of adult autologous stem cells in cardiology** 8 4
11. Support to local research ethics committees 120 109
22. Operational research for SUS (State-level grant applications)*** 1,112 419
Total for 2004 2,493 821
2005 12. Health bioproducts with therapeutic uses** 21 8
12. Network of Clinical Research Centers** 52 14
12. Stem cell therapy – innovative uses** 106 41
14. Health economics and cost evaluation 76 26
19. Leprosy 68 33
05. Cancer research** 243 36
02. Mental health** 146 21
01. Indigenous peoples' health# 61 24
23. Health for the Amazon region 49 15
12. Network for the evaluation of orthopedic materials**,## 32
16. National Demographic and Health Survey### 4 1
Total for 2005* 858 219
Total for the period (2003/2005) 3,962 1,300
* January through October 2005;
** Joint financial disbursements by Department of Science and Technology/Ministry of Health 
and Ministry of Science and Technology;
*** Joint financial disbursements by Department of Science and Technology/Ministry of Health 
and State agencies for research support;
# Joint financial disbursements by Department of Science and Technology/Ministry of Health 
and National Health Foundation;
## Undergoing peer review;
### Joint financial disbursements by Department of Science and Technology/Ministry of Health 
and the Nutrition Division/Ministry of Health.
cional de Saúde – FUNASA), the institution re-
sponsible for indigenous peoples’ health, and
another large project (16. National Demograph-
ic and Health Survey) was financed by DECIT/
Ministry of Health and the Nutrition Division/
Ministry of Health. Most sub-agendas were
contemplated, but some general ones like 15.
Epidemiology, 18. Health Promotion, and 21.
Health Education were contemplated in most
calls for proposals, as the specific themes in-
cluded topics addressing these issues.
Our concern with ethics in research was
clearly expressed in these public calls for pro-
posals. Two of them were specially designed for
institutional support to local ethics commit-
tees, and financial support reached 180 of the
existing 350 committees. This program is run
in close cooperation with the National Research
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Ethics Committee (Comissão Nacional de Ética
em Pesquisa – CONEP) of the National Health
Council.
Another large program, called Operational
Research for SUS, was developed in partner-
ship with all 27 State health departments and
State research support agencies. Funds were
decentralized to State agencies, which in turn
disbursed a complement (from 10% to 100% of
the Ministry of Health funds) and conducted
State-level calls for proposals. These calls for
proposals, already launched twice, have received
a total of more than 1,000 research proposals
(Table 3).
In 2004 the Ministry of Health also support-
ed some projects from sub-agenda 13. Health
Industrial Complex, including the develop-
ment of some vaccines prioritized by the Na-
tional Immunization Program, diagnostic kits
for TB and HCV, NAT tests for HIV, monoclonal
antibodies related to blood transfusions, and
clotting factors by recombinant technology. Al-
so worthy of mention is the partnership with
the Brazilian Cochrane Initiative in order to
strengthen the evidence-based process of tech-
nological incorporation into the SUS.
In 2004, a budget of some US$25 million was
invested by DECIT to support health research
and development. It was wholly disbursed, and
an important point is the operational cost of
running such a program. Out of the total bud-
get, the amount spent directly to finance re-
search corresponded to 97.6%. The majority of
the financial operations described above were
performed with technical advice and opera-
tional cooperation from two Federal research-
financing agencies, namely the CNPq and the
National Agency for Technological Development
(Financiadora de Estudos e Projetos – FINEP),
both under the Ministry of Science and Tech-
nology.
During this period the DECIT/Ministry of
Health relied on a staff of 34 to implement the
agenda, hold the 2nd National Conference on
Science, Technology and Innovation in Health,
and implement research support (calls for pro-
posals, direct contracts, etc). The group con-
sisted primarily of professionals with graduate
diplomas and experience in research (3 PhDs,
17 Masters, and 5 undergraduates), besides 2
public relations professionals and 7 adminis-
trative clerks. Personnel costs were not includ-
ed in the above-mentioned budget figures for
the Department.
Conclusions
The four main functions utilizing knowledge to
improve health and health equity are steward-
ship, financing, creating and sustaining re-
sources, and producing and using research 15.
We have described how these objectives
were accomplished in Brazil including strong
social participation in the process to promote
equity in the policy and agenda. Given adequate
political and financial support, it was possible
to accomplish this in a three-year period. A
process was thus launched to resituate the
Ministry of Health in Brazilian health research
efforts. The remaining challenge is to make
these initial steps permanent and sustainable.
Resumo
A necessidade de estabelecer uma política de ciência e
tecnologia em saúde e prioridades de pesquisa em saú-
de foi destacada no cenário internacional. No Brasil,
estes processos iniciaram em 2003, quando um grupo
designado pelo Conselho Nacional de Saúde propôs 20
subagendas para abarcar as especificidades da pes-
quisa em saúde. O segundo passo foi identificar prio-
ridades em cada subagenda, durante seminários na-
cionais envolvendo 510 cientistas e gestores. A 2a Con-
ferência Nacional de Ciência, Tecnologia e Inovação
em Saúde ocorreu em julho de 2004. Durante a fase
preparatória 307 municípios e 24 Estados organiza-
ram conferências locais, envolvendo 15 mil pessoas.
Do setor saúde foram indicados 360 delegados nas
conferências locais, além dos indicados pelos setores
de educação e ciência e tecnologia. Durante a confe-
rência, a política nacional foi aprovada e três novas
subagendas foram introduzidas e aprovadas. Atual-
mente, a política nacional e a agenda de prioridades
estão guiando os investimentos de recursos para pes-
quisa e desenvolvimento do Ministério da Saúde e, de
certa forma, do Ministério da Ciência e Tecnologia.
Entre 2003 e 2005, 24 editais de pesquisa foram lança-
dos, nos quais foram recebidas 3.962 propostas de pes-
quisa e aprovadas 1.300.
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